Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology
China Biotechnology  2023, Vol. 43 Issue (9): 113-119    DOI: 10.13523/j.cb.2304041
    
Analysis of the Current Situation of Regional Division of Labor in China’s Pharmaceutical Manufacturing Industry
SANG Xiao-dong,WEI Wei,ZHANG Xiao-yi,LI Su-ning,PUN Run,AO Yi,FAN Ling*()
China National Center for Biotechnology Development, Beijing 100039, China
Download: HTML   PDF(591KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: Based on the regional differences in the development of China’s pharmaceutical manufacturing industry, this paper aims to understand and grasp the rules and development trends of the division of labor of the industry by analyzing the regional division of labor in various provinces and regions, and provide decision-making basis and feasible suggestions for constructing a feasible path for high-quality development of China’s biomedical industry. Methods: Based on the available relevant indicators of the pharmaceutical manufacturing industry from 2010 to 2020 and from the perspective of regional economics, we analyzed the regional division of labor and agglomeration of China’s pharmaceutical manufacturing industry using quantitative indicators such as concentration ration and location quotient. Results: From 2010 to 2020, we observed an overall upward trend in industrial concentration in the Beijing-Tianjin-Hebei region, the Yangtze River Delta region, the Guangdong-Hong Kong-Macao Greater Bay Area, and the Chengdu-Chongqing region, showing a high degree of industrial agglomeration. The overall location entropy and scale concentration in the eastern provinces of China showed an increasing trend, with a relatively good performance of regional agglomeration effect. The location entropy showed a relatively stable development and a decreasing trend in the central provinces of China and in the western and northeastern provinces of China, respectively. The pharmaceutical manufacturing industry is expected to become a secondary leading specialized sector in Jiangsu and Shandong provinces in the future, and is an optional leading specialized sector in Beijing, Jiangxi, Hubei, and Sichuan provinces. Conclusion: The pharmaceutical manufacturing industry has become a pillar industry in the economic development of some regions in China. It has showed a gradually emerging trend of industrial agglomeration, and differentiation of the regional division is obvious in the eastern, central, and western regions. It is expected that China’s biopharmaceutical industry chain division and specialized development can be achieved, and its high-quality development can be promoted through strategic planning, top-level design, system supply, and service management at the national level.

Key words： Pharmaceutical manufacturing industry      Regional division of labor      Concentration ration of industry      Location quotient      Leading industrial sector     
Received: 18 April 2023      Published: 08 October 2023
ZTFLH:  Q815  
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
Xiao-dong SANG
Wei WEI
Xiao-yi ZHANG
Su-ning LI
Run PUN
Yi AO
Ling FAN
Cite this article:

SANG Xiao-dong, WEI Wei, ZHANG Xiao-yi, LI Su-ning, PUN Run, AO Yi, FAN Ling. Analysis of the Current Situation of Regional Division of Labor in China’s Pharmaceutical Manufacturing Industry. China Biotechnology, 2023, 43(9): 113-119.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.2304041     OR     https://manu60.magtech.com.cn/biotech/Y2023/V43/I9/113

Fig.1 Industrial concentration results of major clusters of China’s pharmaceutical manufacturing industry
省(市) 年份
2010 2011 2012 2013 2014 2015 2016 2018 2019
北京 1.52 1.61 1.67 1.69 1.59 1.64 1.68 2.27 2.48
天津 1.11 1.02 1.04 0.97 0.9 0.88 0.9 1.24 1.35
河北 1.01 0.91 0.91 0.94 0.9 0.86 0.82 1 0.83
上海 0.78 0.76 0.81 0.86 0.82 0.83 0.86 0.95 1.09
江苏 0.94 0.97 1.02 1.06 1.02 1.02 1.02 1.12 1.22
浙江 0.89 0.86 0.87 0.82 0.8 0.79 0.78 0.87 0.91
福建 0.39 0.37 0.32 0.32 0.29 0.29 0.28 0.28 0.31
山东 1.14 1.14 1.18 1.32 1.23 1.23 1.24 1.2 1.32
广东 0.54 0.52 0.55 0.64 0.53 0.51 0.49 0.5 0.48
海南 2.71 2.59 2.83 3.03 3.08 3.57 3.63 4.46 4.66
Table 1 Location entropy of eastern provinces
省份 年份
2010 2011 2012 2013 2014 2015 2016 2018 2019
山西 0.44 0.34 0.34 0.42 0.45 0.51 0.52 0.46 0.49
安徽 0.87 0.84 0.85 0.83 0.81 0.79 0.8 0.97 0.96
江西 2 1.87 1.82 1.71 1.57 1.5 1.43 1.44 1.54
河南 1.19 1.27 1.12 1.13 1.16 1.16 1.17 1.04 0.94
湖北 1.17 1.12 1.14 1.13 1.08 1.07 1.07 1.28 1.18
湖南 1.19 1.06 1.05 1.09 1.09 1.13 1.13 1.13 1.17
Table 2 Location entropy of central provinces
省(区、市) 年份
2010 2011 2012 2013 2014 2015 2016 2018 2019
内蒙古 0.76 0.85 0.54 0.65 0.62 0.6 0.57 0.47 0.41
广西 1.01 0.97 0.87 0.93 0.83 0.75 0.76 0.39 0.47
重庆 1.15 1.04 1.03 1.01 0.95 1.07 1.06 1.16 1.17
四川 1.57 1.64 1.45 1.39 1.38 1.3 1.29 1.4 1.44
贵州 2.13 2.04 1.53 1.66 1.63 1.46 1.4 1.32 1.3
云南 1.26 1.21 1.19 1.21 1.13 1.12 1.18 1.22 1.08
西藏 5.22 4.16 4.49 6.32 6.44 3.13 2.32 1.77 2.42
陕西 1.1 1.01 1.03 1.12 1.1 1.11 1.13 1.2 1.18
甘肃 0.57 0.49 0.5 0.51 0.53 0.54 0.55 0.54 0.72
青海 0.77 0.67 0.99 1.02 0.89 0.7 0.68 0.4 0.39
宁夏 0.71 0.62 0.38 0.37 0.37 0.45 0.57 0.52 0.4
新疆 0.11 0.1 0.11 0.11 0.12 0.15 0.2 0.3 0.3
Table 3 Location entropy of western provinces
省份 年份
2010 2011 2012 2013 2014 2015 2016 2018 2019
辽宁 0.73 0.74 0.74 0.75 0.76 0.8 0.74 0.86 0.78
吉林 2.5 2.69 2.66 2.84 3.01 3.17 3.25 1.71 1.73
黑龙江 1.74 1.76 1.57 1.54 1.42 1.43 1.39 1.52 1.45
Table 4 Location entropy of northeast provinces
主营业务
收入比重		 区位熵
≥2 ≥1.5 ≥1
≥15% - - -
≥10% - - 江苏省、山东省
≥5% 北京市 江西省 湖北省、四川省
Table 5 Selection results of leading industrial sectors in China’s Provinces
[1]   唐家龙. 新阶段我国生物医药产业的发展态势与对策建议. 科技与金融, 2021(5): 5-10.
[1]   Tang J L. Development trend and countermeasures of China’s biomedical industry in the new stage. STF Monthly, 2021(5): 5-10.
[2]   陈凯先. 生物医药科技创新前沿、我国发展态势和新阶段的若干思考. 中国食品药品监管, 2021(8): 4-17.
[2]   Chen K X. Advances in biopharmaceutical science and technology, innovative biologics in China and discussion of drug development at the new development stage. China Food Drug Administration, 2021(8): 4-17.
[3]   张晓燕, 倪春霞. 中国医药制造业的市场结构分析. 医院管理论坛, 2016, 33(8):6-8.
[3]   Zhang X Y, Ni C X. Analysis on market structure of China’s pharmaceutical manufacturing industry. Hospital Management Forum, 2016, 33(8):6-8.
[4]   褚淑贞, 沈念伍. 基于区位商的医药制造业区域结构分析. 上海医药, 2011, 32(9): 457-461.
[4]   Chu S Z, Shen N W. The region structure analysis of the pharmaceutical manufacturing based on the location quotient. Shanghai Medical&Pharmaceutical Journal, 2011, 32(9):457-461.
[5]   那威. 京津冀工业主导产业现状分析. 现代经济信息, 2013(14): 429-429.
[5]   Na W. Analysis on the present situation of leading industries in Beijing, Tianjin and Hebei. Modern Economic Information, 2013(14): 429-429.
[6]   濮润, 董丽娟, 唐尚锋, 等. 我国区域生物医药产业分工研究. 医药导报, 2019, 38(10):1376-1378.
[6]   Pu R, Dong L J, Tang S F, et al. Research on division of labor of regional biomedical industry in China. Herald of Medicine, 2019, 38(10):1376-1378.
[7]   龙晖, 齐铮, 吴昊. 重庆市生物医药产业发展现状与对策建议: 以人才链为牵引加快生物医药高新园区社区建设. 中国生物工程杂志, 2023, 43(5): 94-105.
[7]   Long H, Qi Z, Wu H. Development status and countermeasures of Chongqing biomedicine industry: accelerating the construction of biomedical high-tech parks with the “talent chain” as the driving force. China Biotechnology, 2023, 43(5): 94-105.
[8]   赵奚. 吉林省生物产业发展困境探析与突破. 科技和产业, 2020, 20(4):109-111.
[8]   Zhao X. Analysis and breakthrough to the development dilemma of Jilin Province’s biological industry. Science Technology and Industry, 2020, 20(4):109-111.
[9]   张琪绮, 卜琳麟, 苏红. 基于熵值法的长三角地区生物医药产业集群竞争力分析. 中国医药工业杂志, 2022, 53(5):754-759.
[9]   Zhang Q Q, Bu L L, Su H. Competitiveness analysis of pharmaceutical industry cluster in the Yangtze River Delta based on entropy method. Chinese Journal of Pharmaceuticals, 2022, 53(5):754-759.
[10]   徐凯, 孙利华. 我国生物医药产业园区发展现状及存在问题. 中国新药杂志, 2019, 28(20): 2440-2446.
[10]   Xu K, Sun L H. Development status and existing problems of biopharmaceutical industrial parks in China. Chinese Journal of New Drugs, 2019, 28(20):2440-2446.
No related articles found!
主管：中国科学院 　主办：中国科学院文献情报中心 　中国生物技术发展中心 　中国生物工程学会